NCH89 is a patient-derived IDH wildtype glioblastoma cell line established from a primary WHO grade IV tumour obtained from a 41 year old female patient. Cells grow as adherent monolayer…
| Inventor | Institute |
|---|---|
| Christel Herold-Mende | Heidelberg University |
| SKU: | 162308 |
|---|---|
| Product description: | NCH89 is a patient-derived IDH wildtype glioblastoma cell line established from a primary WHO grade IV tumour obtained from a 41 year old female patient. Cells grow as adherent monolayer cultures under standard conditions.. |
| Production details: | Patient-derived cell line established from human tumour tissue obtained during surgical resection and expanded in vitro. |
| Cat. #: | 162308 |
|---|---|
| Cancer types: | Brain cancer |
| Organism: | Human |
| Tissue: | Brain |
| Morphology: | Adherent |
| Growth properties: | Cells grow as adherent monolayer cultures under standard culture conditions at 37°C in a humidified incubator with 5% CO2. Medium is replaced twice per week. |
| Primary citation: | Karcher et al. 2005. Cancer Cell Biol. 118(9):2182-2189. PMID: 16331629. |
| Growth medium: | DMEM (high glucose) supplemented with 10% fetal calf serum (FCS), 1% GlutaMAX, and 1% penicillin/streptomycin. |
|---|---|
| Subculture routine: | Cells are passaged at sub-confluent densities using 0.05% Trypsin-EDTA. After enzymatic detachment, trypsin is neutralised with serum-containing medium and cells are reseeded into fresh culture vessels. Passage number should be recorded. |
| Temperature: | 37°C |
| References: |
Fermi et al. 2022. Chemistry. 28(34):e202104535. PMID: 35293640. Wirthschaft et al. 2019. Acta Neuropathol. 138(2):275-293. PMID: 31062076. Schule et al. 2012. Scientific World Journal. 2012:697313. PMID: 22919349. Fassl et al. 2012. Oncogene. 31(44):4698-4708. PMID: 22249262. Campos et al. 2011. Am J Pathol. 178(5):1953-1964. PMID: 21514413. Wentzel et al., 2010 J Med Chem 53(8):3214-26, PMID: 20329733 Konkarevic et al. 2009. Free Radic Biol Med. 46(8):1096-108. PMID: 19439228. Tagscherer et al. 2008. Oncogene. 27(52):6646-6656. PMID: 18663354. Siegelin et al. 2008. Mol Cancer Ther. 7(11):3566-3574. PMID: 19001439. Kleber et al. 2008. Cancer Cell. 13(3):235-248. PMID: 18328427. Combs et al. 2007. Int J Rad Oncol Biol Phys. 71(4):972-978. PMID: 18337022. Karcher et al. 2005. Cancer Cell Biol. 118(9):2182-2189. PMID: 16331629. Steiner et al. 2004. J Neurooncol. 66(1-2):129-138. PMID: 15015778. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.